Further immunological analysis revealed that male patients had a lower percentage of CD4+ T cells and CD19+ B cells than female patients during the infection and recovery of COVID-19, and the response of protective antibodies was slower in male patients than in female patients. The gene discussed is CD19; the disease is COVID-19.